Targeting PDGF pathway in pulmonary arterial hypertension

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.11, 2012-11, pp. : 1055-1063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting RhoA/ROCK pathway in pulmonary arterial hypertension

By Antoniu Sabina Antonela

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 355-363

Informa Healthcare

Access to resources Recommend Favorite

Tadalafil: In Pulmonary Arterial Hypertension

By Croxtall Jamie D. Lyseng-Williamson Katherine A.

Drugs, Vol. 70, Iss. 4, 2010-03 ,pp. : 479-488

Adis International

Access to resources Recommend Favorite

Terguride for pulmonary arterial hypertension

By Antoniu Sabina A

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. : 1333-1335

Informa Healthcare

Access to resources Recommend Favorite

Sitaxentan: In Pulmonary Arterial Hypertension

By Scott Lesley J.

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 761-770

Adis International

Access to resources Recommend Favorite

Dasatinib linked to pulmonary arterial hypertension

Reactions Weekly, Vol. 1, Iss. 1368, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite